Lime Chemicals

  • Market Cap: Micro Cap
  • Industry: Commodity Chemicals
  • ISIN: INE891G01011
  • NSEID:
  • BSEID: 507759
INR
15.35
0.00 (0.00%)
BSENSE

Jun 19, 03:30 PM

BSE+NSE Vol: 636

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

636 (-6.94%) Volume

Shareholding (Mar 2026)

FII

0.00%

Held by 0 FIIs

DII

0.05%

Held by 0 DIIs

Promoter

29.27%

Why is Lime Chemicals Ltd falling/rising?

19-Jun-2026

As of 19-Jun, the stock price of Lime Chemicals Ltd is stable at 15.35, with a year-to-date increase of 13.20%. Despite recent trading volume declines and sector underperformance, the stock shows potential for future growth due to its strong performance and trading above moving averages.

As of 19-Jun, the stock price of Lime Chemicals Ltd is currently stable at 15.35, showing no change (0.00%). Despite this stability, the stock has demonstrated a mixed performance in various time frames. Over the past week, it has risen by 4.42%, outperforming the Sensex, which increased by 1.69%. In the past month, the stock has also shown a positive return of 3.65%, compared to the Sensex's 2.13% gain.<BR><BR>However, the year-to-date performance is notably strong, with a 13.20% increase, while the Sensex has declined by 9.88%. This indicates that, despite recent challenges, the stock has been resilient in the longer term. <BR><BR>In terms of trading activity, the stock has underperformed its sector by 1% today, and there has been erratic trading, as it did not trade on one day out of the last 20. Additionally, there has been a significant drop in investor participation, with delivery volume on June 17 falling by 62.23% compared to the 5-day average. <BR><BR>On a positive note, Lime Chemicals is trading above its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically indicates a bullish trend. <BR><BR>Overall, while the stock price is currently stable, the combination of strong year-to-date performance, positive short-term gains, and trading above moving averages suggests a potential for future growth, despite the recent decline in trading volume and sector underperformance.

View full answer

How big is Lime Chemicals?

11-Jun-2026

As of 10th June, Lime Chemicals Ltd has a market capitalization of 9.00 Cr and reported Net Sales of 7.12 Cr with a Net Profit loss of 0.18 Cr over the latest four quarters. Shareholder's Funds were 1.94 Cr and Total Assets were 10.10 Cr as of March 2025.

As of 10th June, Lime Chemicals Ltd has a market capitalization of 9.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Lime Chemicals reported Net Sales of 7.12 Cr. However, the company experienced a loss of 0.18 Cr in Net Profit during the same period.<BR><BR>The latest annual period for the balance sheet is March 2025, where Shareholder's Funds amounted to 1.94 Cr and Total Assets were reported at 10.10 Cr.

View full answer

Who are in the management team of Lime Chemicals?

11-Jun-2026

The management team of Lime Chemicals includes A H Dawoodani (Managing Director), Shahnaz A Dawoodani and Akbar Virani (Directors), Husen Somji (Independent Director), Avinash Mukesh Jhaveri (Chairman & Independent Director), and S. Neha T. Botadra (Company Secretary & Compliance Officer).

The management team of Lime Chemicals includes the following individuals:<BR><BR>1. A H Dawoodani - Managing Director<BR>2. Shahnaz A Dawoodani - Director<BR>3. Akbar Virani - Director<BR>4. Husen Somji - Independent Director<BR>5. Avinash Mukesh Jhaveri - Chairman & Independent Director<BR>6. S. Neha T. Botadra - Company Secretary & Compliance Officer<BR><BR>If you need more details about their roles or the company, feel free to ask!

View full answer

Who are the peers of the Lime Chemicals?

11-Jun-2026

Peers of Lime Chemicals include Square Four Pro., Kobo Biotech, Sreechem Resins, Emmessar Biotech, Kuwer Industries, Link Pharma Chem, Bhagawati Oxygen, and Padmanabh Inds. Sreechem Resins shows excellent management risk and growth, while Lime Chemicals has average management risk and below-average growth, with a 1-year return of -19.54%.

Peers: The peers of Lime Chemicals are Square Four Pro., Kobo Biotech, Sreechem Resins, Emmessar Biotech, Kuwer Industries, Link Pharma Chem, Bhagawati Oxygen, and Padmanabh Inds.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sreechem Resins, while Average management risk is found at Emmessar Biotech, Kuwer Industries, Link Pharma Chem, and Lime Chemicals. Below Average management risk is present at Square Four Pro., Kobo Biotech, and Bhagawati Oxygen, with Padmanabh Inds. also rated as Below Average. Growth is rated as Good at Sreechem Resins, Average at Padmanabh Inds., and Below Average at Emmessar Biotech, Kuwer Industries, Link Pharma Chem, and Lime Chemicals, while Square Four Pro. and Kobo Biotech do not qualify. Capital Structure is rated as Good at Sreechem Resins, Average at Padmanabh Inds., and Below Average at Emmessar Biotech, Kuwer Industries, Link Pharma Chem, Lime Chemicals, Square Four Pro., Kobo Biotech, and Bhagawati Oxygen.<BR><BR>Return Snapshot: Kobo Biotech has the highest 1-year return at 134.11%, while Bhagawati Oxygen has the lowest at -37.07%. Lime Chemicals' 1-year return is -19.54%, which is better than Bhagawati Oxygen but worse than Kobo Biotech. Additionally, Emmessar Biotech, Link Pharma Chem, Bhagawati Oxygen, and Padmanabh Inds. have negative six-month returns.

View full answer

What does Lime Chemicals do?

10-Jun-2026

Lime Chemicals Ltd manufactures Calcium Carbonate and operates in the Commodity Chemicals industry as a Micro Cap company. Founded in 1970, it reported net sales of 2 Cr and a net profit of 0 Cr for the quarter ending March 2026, with a market cap of INR 9 Cr.

Overview: <BR>Lime Chemicals Ltd is engaged in the manufacture of Calcium Carbonate and operates within the Commodity Chemicals industry, classified as a Micro Cap company.<BR><BR>History: <BR>Lime Chemicals Ltd was incorporated in 1970 in Maharashtra. The company went public in 1986, marking a significant milestone in its development. The latest quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 2 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 0 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 9 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 42 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 2.47 <BR>Return on Equity: -10.06% <BR>Price to Book: 5.16<BR><BR>Contact Details: <BR>Address: 404/405 Neco Chambers 4 Th Flo, Plot No 48 Sector 11 Navi Mumbai Maharashtra : 400614 <BR>Tel: 91-022-27561976/77 <BR>Email: info@limechem.com <BR>Website: http://www.limechem.com

View full answer

Should I buy, sell or hold Lime Chemicals Ltd?

03-Jun-2026

Are Lime Chemicals Ltd latest results good or bad?

02-Jun-2026

Lime Chemicals Ltd's latest results show mixed performance, with a net profit of ₹0.03 crores and significant revenue growth, but ongoing challenges such as negative operating margins and a 20.39% decline in annual net sales raise concerns about its financial health. Investor sentiment is cautious, reflected in a "Strong Sell" rating due to working capital stress and negative equity.

Lime Chemicals Ltd's latest results present a mixed picture. On one hand, the company reported a net profit of ₹0.03 crores in Q4 FY26, which is an improvement from a loss of ₹0.08 crores in the previous quarter. Additionally, there was a significant revenue growth of 39.02% year-on-year, reaching ₹2.28 crores, and a robust 49.02% increase quarter-on-quarter.<BR><BR>However, despite these positive trends, the company continues to face serious challenges. The operating margin remains negative at -1.75%, indicating that core business operations are still loss-making. Furthermore, the annual performance shows a concerning decline in net sales of 20.39% for the nine-month period ending in FY26 compared to the same period in FY25.<BR><BR>Investor sentiment appears to be cautious, as reflected in the stock's recent decline and a "Strong Sell" rating. The company's financial health is also under scrutiny due to significant working capital stress, with current liabilities exceeding current assets, and a negative equity base.<BR><BR>In summary, while there are some signs of improvement, the overall financial situation remains precarious, and the company faces ongoing operational challenges that could hinder its recovery.

View full answer

How has been the historical performance of Lime Chemicals?

17-Nov-2025

Lime Chemicals has experienced a significant decline in net sales and profitability from INR 43.44 crore in March 2019 to INR 9.67 crore in March 2025, with negative operating profit margins and decreasing profit before and after tax. The company faces ongoing financial challenges, reflected in negative cash flow and reduced total assets and liabilities.

Answer:<BR>The historical performance of Lime Chemicals shows a declining trend in net sales and profitability over the years, with significant fluctuations in various financial metrics.<BR><BR>Breakdown:<BR>Lime Chemicals has experienced a steady decline in net sales from INR 43.44 crore in March 2019 to INR 9.67 crore in March 2025. The total operating income followed a similar trend, decreasing from INR 43.44 crore in March 2019 to INR 9.67 crore in March 2025. The raw material costs and purchase of finished goods have also varied, with raw material costs rising to INR 3.19 crore in March 2025 from INR 0.44 crore in March 2023. The company reported an operating profit margin that turned negative in recent years, reaching -1.34% in March 2025, compared to a positive margin of 7.87% in March 2019. Profit before tax showed a decline, with a profit of INR 0.24 crore in March 2025, down from INR 3.08 crore in March 2023. The profit after tax also reflected this downward trend, with INR 0.22 crore in March 2025 compared to INR 2.76 crore in March 2023. The company's total liabilities decreased from INR 24.07 crore in March 2020 to INR 10.10 crore in March 2025, while total assets also fell from INR 24.07 crore to INR 10.10 crore in the same period. Cash flow from operating activities has been negative in recent years, indicating ongoing financial challenges. Overall, Lime Chemicals has faced significant operational and financial difficulties, leading to a decline in key performance metrics over the years.

View full answer

When is the next results date for Lime Chemicals?

07-Nov-2025

The next results date for Lime Chemicals is 14 November 2025.

The next results date for Lime Chemicals is scheduled for 14 November 2025.

View full answer

Who are the top shareholders of the Lime Chemicals?

17-Jul-2025

The top shareholders of Lime Chemicals include Rahim Ahmed Dawoodani with 10.62%, Devanshi Parimal Merchant with 12.3%, and individual investors holding 64.14%. There is also a foreign institutional investor with 2.35% and five mutual fund schemes with a combined 0.05%, with no pledged promoter holdings.

The top shareholders of Lime Chemicals include both individual and institutional investors. The promoter with the highest holding is Rahim Ahmed Dawoodani, who owns 10.62% of the company. The highest public shareholder is Devanshi Parimal Merchant, holding 12.3%. Additionally, individual investors collectively hold a significant portion of 64.14%. There is also some institutional presence, with one foreign institutional investor (FII) holding 2.35% and five mutual fund schemes holding a combined 0.05%. Notably, there are no pledged promoter holdings.

View full answer

Is Lime Chemicals overvalued or undervalued?

09-Jun-2025

As of April 25, 2023, Lime Chemicals is considered overvalued and classified as "risky," with a PE ratio of 11.25, a Price to Book Value of 6.39, and a year-to-date return of -26.83%, significantly underperforming compared to its peers like Solar Industries and Godrej Industries.

As of 25 April 2023, Lime Chemicals has moved from a grade of "does not qualify" to "risky." The company is currently considered overvalued. Key ratios include a PE ratio of 11.25, a Price to Book Value of 6.39, and a PEG ratio of 0.08, which indicates a significant disparity in valuation metrics compared to its peers. <BR><BR>In comparison to its peers, Lime Chemicals' PE ratio is notably lower than Solar Industries, which has a PE of 123.77, and Godrej Industries, which stands at 46.63. The EV to EBITDA ratio of Lime Chemicals is -16.10, contrasting sharply with Godrej Industries' 34.36, highlighting its poor profitability relative to industry standards. Additionally, the company's recent stock performance has been underwhelming, with a year-to-date return of -26.83% compared to a 5.62% gain in the Sensex, reinforcing the notion of its overvaluation amidst a challenging market environment.

View full answer

What is the technical trend for Lime Chemicals?

09-Jun-2025

As of May 14, 2025, Lime Chemicals is in a mildly bearish trend, with daily moving averages and weekly Dow Theory indicating bearish sentiment, while mixed signals from MACD, Bollinger Bands, and KST suggest potential for stabilization.

As of 14 May 2025, the technical trend for Lime Chemicals has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the daily moving averages indicating a bearish sentiment and the weekly Dow Theory also reflecting a mildly bearish outlook. The MACD shows a mildly bullish signal on the weekly chart but remains bearish on the monthly, which adds to the mixed signals. The Bollinger Bands and KST both indicate bearish conditions on the monthly, while the RSI shows no significant signals in either time frame. Overall, the strength of the bearish trend is moderate, with some conflicting indicators suggesting potential for stabilization.

View full answer

Has Lime Chemicals declared dividend?

06-Jun-2025

Lime Chemicals Ltd has declared a 12% dividend, amounting to 0.9700 per share, with an ex-date of September 25, 2006. However, the dividend yield is 0%, and total returns over various periods have shown significant losses.

Lime Chemicals Ltd has declared a 12% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 12%<BR>- Amount per share: 0.9700<BR>- Ex-date: 25 Sep 06<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -33.64%, the dividend return was 0%, resulting in a total return of -33.64%.<BR><BR>For the 1-year period, the price return was -32.63%, the dividend return was 0%, leading to a total return of -32.63%.<BR><BR>Over the 2-year period, the price return was -23.64%, the dividend return was 0%, which resulted in a total return of -23.64%.<BR><BR>In the 3-year period, the price return was -34.55%, with a dividend return of 0%, culminating in a total return of -34.55%.<BR><BR>During the 4-year period, the price return was -42.15%, the dividend return was 0%, resulting in a total return of -42.15%.<BR><BR>For the 5-year period, the price return was -23.47%, the dividend return was 0%, leading to a total return of -23.47%.<BR><BR>Overall, while Lime Chemicals Ltd has declared a dividend, the dividend yield is 0%, indicating no returns from dividends in recent periods. The total returns across various periods reflect significant losses, suggesting a challenging financial performance.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of -20.32% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) of 2.56 times
2

Flat results in Mar 26

3

Risky - Negative EBITDA

4

Falling Participation by Institutional Investors

5

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 10 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

43

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

2.47

stock-summary
Return on Equity

-10.06%

stock-summary
Price to Book

5.58

Revenue and Profits:
Net Sales:
2 Cr
(Quarterly Results - Mar 2026)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
17.18%
0%
17.18%
6 Months
20.87%
0%
20.87%
1 Year
-9.44%
0%
-9.44%
2 Years
-41.28%
0%
-41.28%
3 Years
-31.99%
0%
-31.99%
4 Years
-38.6%
0%
-38.6%
5 Years
-50.16%
0%
-50.16%

Latest dividend: 0.9700 per share ex-dividend date: Sep-25-2006

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Audited Quarterly And Yearly Financial Results For The Quarter And Year Ended On 31St March 2026

30-May-2026 | Source : BSE

Audited financial results for the quarter and year ended on 31st March 2026 is attached herewith.

Board Meeting Outcome for Outcome Of Board Meeting Held On 30Th May 2026

30-May-2026 | Source : BSE

Outcome of the Board Meeting held on 30th May 2026 is attached herewith.

Board Meeting Intimation for Board Meeting On 30Th May 2026 To Approve Audited Financial Results For The Quarter And Year Ended On 31St March 2026.

22-May-2026 | Source : BSE

Lime Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve A meeting of the Board of Directors of the Company will be held on Saturday the 30th May 2026 to approve audited financial results for the quarter and year ended on 31st March 2026.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Lime Chemicals Ltd has declared 12% dividend, ex-date: 25 Sep 06

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-20.32%
EBIT Growth (5y)
10.99%
EBIT to Interest (avg)
-0.59
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
2.47
Sales to Capital Employed (avg)
1.70
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.05%
ROCE (avg)
-11.90%
ROE (avg)
2.27%

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
43
Price to Book Value
5.58
EV to EBIT
-14.41
EV to EBITDA
-14.41
EV to Capital Employed
2.32
EV to Sales
2.02
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-8.52%
ROE (Latest)
-10.06%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 5 Schemes (0.05%)

FIIs

Held by 0 FIIs

Promoter with highest holding

Rahim Ahmed Dawoodani (10.62%)

Highest Public shareholder

Devanshi Parimal Merchant (12.3%)

Individual Investors Holdings

66.3%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 39.02% vs -30.51% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -50.00% vs 154.55% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.28",
          "val2": "1.64",
          "chgp": "39.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.04",
          "val2": "-0.25",
          "chgp": "84.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.02",
          "val2": "0.15",
          "chgp": "-86.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.03",
          "val2": "0.06",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1.75%",
          "val2": "-15.24%",
          "chgp": "13.49%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -38.93% vs -1.45% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -230.00% vs 131.25% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.31",
          "val2": "5.42",
          "chgp": "-38.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.33",
          "val2": "0.06",
          "chgp": "-650.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.01",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.13",
          "val2": "0.10",
          "chgp": "-230.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-9.97%",
          "val2": "1.11%",
          "chgp": "-11.08%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -39.65% vs -0.87% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -231.25% vs 142.11% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.84",
          "val2": "8.02",
          "chgp": "-39.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.42",
          "val2": "0.10",
          "chgp": "-520.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.01",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.21",
          "val2": "0.16",
          "chgp": "-231.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-8.68%",
          "val2": "1.25%",
          "chgp": "-9.93%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -26.37% vs -7.46% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -177.27% vs 144.90% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7.12",
          "val2": "9.67",
          "chgp": "-26.37%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.46",
          "val2": "-0.13",
          "chgp": "-253.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.03",
          "val2": "0.15",
          "chgp": "-80.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.17",
          "val2": "0.22",
          "chgp": "-177.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-6.46%",
          "val2": "-1.34%",
          "chgp": "-5.12%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
2.28
1.64
39.02%
Operating Profit (PBDIT) excl Other Income
-0.04
-0.25
84.00%
Interest
0.02
0.15
-86.67%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.03
0.06
-50.00%
Operating Profit Margin (Excl OI)
-1.75%
-15.24%
13.49%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2026 is 39.02% vs -30.51% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Mar 2026 is -50.00% vs 154.55% in Mar 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
3.31
5.42
-38.93%
Operating Profit (PBDIT) excl Other Income
-0.33
0.06
-650.00%
Interest
0.01
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.13
0.10
-230.00%
Operating Profit Margin (Excl OI)
-9.97%
1.11%
-11.08%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -38.93% vs -1.45% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -230.00% vs 131.25% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
4.84
8.02
-39.65%
Operating Profit (PBDIT) excl Other Income
-0.42
0.10
-520.00%
Interest
0.01
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.21
0.16
-231.25%
Operating Profit Margin (Excl OI)
-8.68%
1.25%
-9.93%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is -39.65% vs -0.87% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -231.25% vs 142.11% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
7.12
9.67
-26.37%
Operating Profit (PBDIT) excl Other Income
-0.46
-0.13
-253.85%
Interest
0.03
0.15
-80.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.17
0.22
-177.27%
Operating Profit Margin (Excl OI)
-6.46%
-1.34%
-5.12%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is -26.37% vs -7.46% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is -177.27% vs 144.90% in Mar 2025

stock-summaryCompany CV
About Lime Chemicals Ltd stock-summary
stock-summary
Lime Chemicals Ltd
Micro Cap
Commodity Chemicals
Lime Chemicals Limited (LCL) was incorporated in 1970 in Maharashtra. The Company is engaged in manufacture of Calcium Carbonate including Tooth Paste, Pharmaceuticals, PVC products, Rubber, Plastic, Polymer, Cable, Leather, Paper and Paints. Upgradation of technology & continuous product development gave the Company strength to consolidate its position in the Indian market, and the first major milestone it achieved was in 1986 when the Company went Public.
Company Coordinates stock-summary
Company Details
404/405 Neco Chambers 4 Th Flo, Plot No 48 Sector 11 Navi Mumbai Maharashtra : 400614
stock-summary
Tel: 91-022-27561976/77
stock-summary
info@limechem.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai